The standardized mortality rate for Parkinson's Disease for men in the US is set to rise steadily from 2024 to 2028. The projected figures indicate a yearly increase in mortality rate, starting at 21.2 deaths per 100,000 men in 2024 and reaching 24.2 by 2028. Comparing year-on-year growth, the increase from 2025 to 2026 is approximately 3.7%, and from 2026 to 2027 is approximately 3.1%. Over the five-year period from 2024 to 2028, the Compound Annual Growth Rate (CAGR) is about 3.4%.
Future trends to monitor include advances in medical treatments and potential disease management improvements that could alter these forecasts. Emerging healthcare policies and Parkinson's research breakthroughs may play significant roles in potentially stabilizing or reducing the rate of increase in mortality.
